Neuronetics, Inc. (STIM)
NASDAQ: STIM · Real-Time Price · USD
2.980
+0.090 (3.11%)
At close: Aug 25, 2026, 4:00 PM EDT
2.970
-0.010 (-0.34%)
After-hours: Aug 25, 2026, 7:16 PM EDT
Neuronetics Employees
Neuronetics had 658 employees as of December 31, 2025. The number of employees decreased by 58 or -8.10% compared to the previous year.
Employees
658
Change (1Y)
-58
Growth (1Y)
-8.10%
Revenue / Employee
$235,708
Profits / Employee
-$46,249
Market Cap
227.07M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 658 | -58 | -8.10% |
| Dec 31, 2024 | 716 | 513 | 252.71% |
| Sep 30, 2024 | 201 | -10 | -4.74% |
| Jun 30, 2024 | 203 | -6 | -2.87% |
| Mar 31, 2024 | 202 | 2 | 1.00% |
| Dec 31, 2023 | 203 | 9 | 4.64% |
| Sep 30, 2023 | 211 | 13 | 6.57% |
| Jun 30, 2023 | 209 | 25 | 13.59% |
| Mar 31, 2023 | 200 | 13 | 6.95% |
| Dec 31, 2022 | 194 | 19 | 10.86% |
| Sep 30, 2022 | 198 | 33 | 20.00% |
| Jun 30, 2022 | 184 | 23 | 14.29% |
| Mar 31, 2022 | 187 | 40 | 27.21% |
| Dec 31, 2021 | 175 | 49 | 38.89% |
| Sep 30, 2021 | 165 | 43 | 35.25% |
| Jun 30, 2021 | 161 | 47 | 41.23% |
| Mar 31, 2021 | 147 | 30 | 25.64% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| InfuSystem Holdings | 473 |
| RxSight | 461 |
| Treace Medical Concepts | 450 |
| Standard BioTools | 389 |
| AVITA Medical | 226 |
| Electromed | 180 |
| Profound Medical | 162 |
| Quantum-Si incorporated | 145 |
STIM News
- 14 days ago - Neuronetics Earnings Call Transcript: Q2 2026 - Transcripts
- 14 days ago - Neuronetics Slides: Q2 2026 - Filings
- 14 days ago - Neuronetics Earnings release: Q2 2026 - Filings
- 14 days ago - Neuronetics Quarterly report: Q2 2026 - Filings
- 14 days ago - Neuronetics reports Q2 EPS (5c), consensus (12c) - TheFly
- 22 days ago - Neuronetics and Jorey Chernett Announce Shared Vision - GlobeNewsWire
- 25 days ago - Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 4 weeks ago - Greenbrook Opens National Center of Excellence for Advanced Interventional Psychiatry in Rockville, Maryland - GlobeNewsWire